VBIV - VBI Vaccines gains after Phase 2 data for Hep B candidate September, 06 2023 07:33 AM VBI Vaccines Inc. 2023-09-06 07:33:44 ET More on VBI Vaccines VBI Vaccines slides on discounted stock and warrants offering VBI Vaccines down 3% after hours on public offering VBI Vaccines: Recent Updates Have Fortified My Long-Term Outlook For further details see: VBI Vaccines gains after Phase 2 data for Hep B candidate